» Articles » PMID: 27992258

Challenges in the Psychopharmacological Management of Very Early-Onset Schizophrenia and Anxiety

Overview
Publisher Mary Ann Liebert
Date 2016 Dec 20
PMID 27992258
Authors
Affiliations
Soon will be listed here.
References
1.
Maynard T, Sikich L, Lieberman J, LaMantia A . Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull. 2001; 27(3):457-76. DOI: 10.1093/oxfordjournals.schbul.a006887. View

2.
Lieberman J, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K . The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001; 50(11):884-97. DOI: 10.1016/s0006-3223(01)01303-8. View

3.
Cannon M, Caspi A, Moffitt T, Harrington H, Taylor A, Murray R . Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002; 59(5):449-56. DOI: 10.1001/archpsyc.59.5.449. View

4.
Fish B, Kendler K . Abnormal infant neurodevelopment predicts schizophrenia spectrum disorders. J Child Adolesc Psychopharmacol. 2005; 15(3):348-61. DOI: 10.1089/cap.2005.15.348. View

5.
Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N . Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry. 2009; 48(1):10-8. PMC: 2664646. DOI: 10.1097/CHI.0b013e31818b1c63. View